4: Statement of changes in beneficial ownership of securities-Director Barry Richard
Apr 25 21:20
4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William
Apr 22 21:20
4: Statement of changes in beneficial ownership of securities-Officer Schoen Eric
Apr 18 04:26
Cassava Sciences | 8-K: Redemption Date Announced for Warrants
Apr 16 04:05
Cassava Sciences | DEF 14A: Definitive information statements
Mar 26 20:14
Cassava Sciences | ARS: Annual Report to Security Holders
Mar 22 21:02
Cassava Sciences | 10-K: Annual report
Feb 29 05:04
Cassava Sciences | 8-K: Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
Feb 28 22:27
Cassava Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.51%)
Feb 14 07:14
Cassava Sciences | 8-K: No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
Feb 7 22:26
Cassava Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Remi Barbier(5.7%)
Feb 2 05:03
Cassava Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.2%)
Jan 27 05:29
Cassava Sciences | CERT: Others
Jan 3 13:00
Cassava Sciences | 424B2: Prospectus
Jan 3 13:00
Cassava Sciences | 8-A12B: Registration of a class of securities on a national securities exchange
Jan 3 13:00
Cassava Sciences | 8-K: Entry into Material Definitive Agreements
Jan 3 13:00
Cassava Sciences | 8-A12G: Others
Jan 2 13:00
Cassava Sciences | 8-K: Current report
Dec 12, 2023 22:19
Cassava Sciences | 8-K: Current report
Dec 12, 2023 05:18
Cassava Sciences | 4: Statement of changes in beneficial ownership of securities-Director Nicaise Claude
Dec 9, 2023 06:06
No Data
No Data